同仁堂科技(01666.HK):金钗石斛散获淮在港出售

阿斯达克财经
20 Mar

同仁堂科技(01666.HK) 公布,附属公司同仁堂国药近日收到香港中医药管理委员会颁发的《中成药注册证明书》,准许将“金钗石斛散【同仁堂】”在香港出售。药物的注册编号为HKC-18754,证明书有效期限至2030年1月23日止。

该药物功能主治为用于热病津伤,口感烦渴,胃阴不足,食少干呕,病后虚热不退,阴虚火旺,骨蒸劳热,目暗不明,筋骨痿软。目前同仁堂国药就药物的研发投入累计约200万元。(sl/u)(港股报价延迟最少十五分钟。沽空资料截至 2025-03-20 16:25。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10